Ferroptosis
Ferroptosis is a unique iron-dependent form of nonapoptotic cell death. It is triggered by oncogenic RAS-selective lethal small molecule erastin. Acitvation of ferroptosis lead to nonapoptotic destruction of cancer cells.
Products Related to Ferroptosis(211)
- GC11786AcetylcysteineCAS: 616-91-1Purity: >99.00%
Acetylcysteine is an N-acetyl derivative of L-cysteine and a glutathione precursor with mucolytic activity.
- GC11835DeferasiroxCAS: 201530-41-8Purity: >99.50%
Deferasirox is an orally active iron chelator used to treat iron overload diseases.
- GC11882GKT137831CAS: 1218942-37-0Purity: >99.00%
GKT137831, an orally dual NADPH oxidase 1/4 (NOX1/NOX4) inhibitor with potency in the submicromolar range, could prevent oxidative stress in human aortic endothelial cells induced by hyperglycemia and attenuate the development of atherosclerosis in diabetic mice.
- GC12698BAY 87-2243CAS: 1227158-85-1Purity: >99.50%
BAY 87-2243 is a highly potent and selective inhibitor of hypoxia-inducible factor-1 (HIF-1).
- GC13083SiramesineCAS: 147817-50-3Purity: >98%
Siramesine (Lu 28-179) is a potent sigma-2 receptor agonist. Siramesine has a subnanomolar affinity for sigma-2 receptors (IC50=0.12nM) and exhibits a 140-fold selectivity for sigma-2 receptors over sigma-1 receptors (IC50=17nM). Siramesine triggers cell death through destabilisation of mitochondria, but not lysosomes. Anti-cancer activity.
- GC13139FG-4592 (ASP1517)CAS: 808118-40-3Purity: >99.50%
FG-4592 (ASP1517) is an oral bioavailable hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor that stimulates erythropoiesis.
- GC13554Deferoxamine mesylateCAS: 138-14-7Purity: >98.00%
Deferoxamine mesylate is an iron chelator that binds Fe(III) and many other metal cations.
- GC13968SB202190 (FHPI)CAS: 152121-30-7Purity: >99.00%
SB 202190 is a selective p38 MAP kinase inhibitor with IC50s of 50 nM and 100 nM for p38α and p38β2, respectively.
- GC14049(-)-Epigallocatechin gallate (EGCG)CAS: 989-51-5Purity: >98.00%
(-)-Epigallocatechin Gallate sulfate (EGCG) is a major polyphenol in green tea that inhibits cell proliferation and induces apoptosis.
- GC14538Pravastatin sodiumCAS: 81131-70-6Purity: >98.00%
Pravastatin sodium is a reversible competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, with an IC 50 of 5.6μM. Pravastatin sodium is commonly used in the research of hypercholesterolemia and various cardiovascular diseases.
- GC14591Hemin chlorideCAS: 16009-13-5Purity: >98.00%
Hemin chloride, a substrate of heme oxygenase (HO)-1, induces HO-1 expression on a variety of cells to exert anti-oxidant and anti-inflammatory roles.
- GC14948PioglitazoneCAS: 111025-46-8Purity: >99.50%
Pioglitazone belongs to the class of glitazones or thiazolidinediones, a series of oral anti-diabetic drugs.
- GC15222Siramesine hydrochlorideCAS: 224177-60-0Purity: >99.50%
Siramesine hydrochloride is an effective sigma-2 receptor agonist. Siramesine has an annanometer-level affinity for the sigma-2 receptor (IC 50 = 0.12nM), and its selectivity for the sigma-2 receptor is 140 times that of the sigma-1 receptor (IC 50 = 17nM).
- GC15272TroglitazoneCAS: 97322-87-7Purity: >96.00%
Troglitazone is an orally active agonist of the peroxisome proliferator-activated receptor γ (PPARγ), with EC 50 values of 550nM and 780nM for human and murine receptors, respectively.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC11786 | Acetylcysteine | 616-91-1 | >99.00% | |
Acetylcysteine is an N-acetyl derivative of L-cysteine and a glutathione precursor with mucolytic activity. | ||||
| GC11835 | Deferasirox | 201530-41-8 | >99.50% | |
Deferasirox is an orally active iron chelator used to treat iron overload diseases. | ||||
| GC11882 | GKT137831 | 1218942-37-0 | >99.00% | |
GKT137831, an orally dual NADPH oxidase 1/4 (NOX1/NOX4) inhibitor with potency in the submicromolar range, could prevent oxidative stress in human aortic endothelial cells induced by hyperglycemia and attenuate the development of atherosclerosis in diabetic mice. | ||||
| GC11908 | Cisplatin | 15663-27-1 | >98.00% | |
Cisplatin, a platinum-containing anticancer drug, is one of the most commonly used cytotoxic agents for the treatment of a variety of solid malignant tumors. | ||||
| GC12086 | PRIMA-1 | 5608-24-2 | >98.00% | |
A re-activator of the apoptotic function of mutant p53 proteins | ||||
| GC12203 | L-Glutathione Reduced | 70-18-8 | >97.00% | |
Used to elute GST from glutathione agarose | ||||
| GC12205 | PD 146176 | 4079-26-9 | >98.00% | |
PD 146176 is one of the potent and selective inhibitors of reticulocyte 15-LOX-1. | ||||
| GC12431 | RSL3 | 1219810-16-8 | >98.00% | |
RSL3, a GPX4 inhibitor, triggers lipid peroxidation and decreases GPX4 expression. | ||||
| GC12698 | BAY 87-2243 | 1227158-85-1 | >99.50% | |
BAY 87-2243 is a highly potent and selective inhibitor of hypoxia-inducible factor-1 (HIF-1). | ||||
| GC13083 | Siramesine | 147817-50-3 | >98% | |
Siramesine (Lu 28-179) is a potent sigma-2 receptor agonist. Siramesine has a subnanomolar affinity for sigma-2 receptors (IC50=0.12nM) and exhibits a 140-fold selectivity for sigma-2 receptors over sigma-1 receptors (IC50=17nM). Siramesine triggers cell death through destabilisation of mitochondria, but not lysosomes. Anti-cancer activity. | ||||
| GC13139 | FG-4592 (ASP1517) | 808118-40-3 | >99.50% | |
FG-4592 (ASP1517) is an oral bioavailable hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor that stimulates erythropoiesis. | ||||
| GC13554 | Deferoxamine mesylate | 138-14-7 | >98.00% | |
Deferoxamine mesylate is an iron chelator that binds Fe(III) and many other metal cations. | ||||
| GC13968 | SB202190 (FHPI) | 152121-30-7 | >99.00% | |
SB 202190 is a selective p38 MAP kinase inhibitor with IC50s of 50 nM and 100 nM for p38α and p38β2, respectively. | ||||
| GC14038 | Atorvastatin Calcium | 134523-03-8 | >99.50% | |
An HMG-CoA reductase inhibitor | ||||
| GC14049 | (-)-Epigallocatechin gallate (EGCG) | 989-51-5 | >98.00% | |
(-)-Epigallocatechin Gallate sulfate (EGCG) is a major polyphenol in green tea that inhibits cell proliferation and induces apoptosis. | ||||
| GC14538 | Pravastatin sodium | 81131-70-6 | >98.00% | |
Pravastatin sodium is a reversible competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, with an IC 50 of 5.6μM. Pravastatin sodium is commonly used in the research of hypercholesterolemia and various cardiovascular diseases. | ||||
| GC14591 | Hemin chloride | 16009-13-5 | >98.00% | |
Hemin chloride, a substrate of heme oxygenase (HO)-1, induces HO-1 expression on a variety of cells to exert anti-oxidant and anti-inflammatory roles. | ||||
| GC14787 | Curcumin | 458-37-7 | >98.00% | |
A yellow pigment with diverse biological activities | ||||
| GC14827 | Linagliptin (BI-1356) | 668270-12-0 | >99.50% | |
A potent DPP-4 inhibitor | ||||
| GC14948 | Pioglitazone | 111025-46-8 | >99.50% | |
Pioglitazone belongs to the class of glitazones or thiazolidinediones, a series of oral anti-diabetic drugs. | ||||
| GC15130 | Alogliptin (SYR-322) | 850649-61-5 | >99.00% | |
| GC15222 | Siramesine hydrochloride | 224177-60-0 | >99.50% | |
Siramesine hydrochloride is an effective sigma-2 receptor agonist. Siramesine has an annanometer-level affinity for the sigma-2 receptor (IC 50 = 0.12nM), and its selectivity for the sigma-2 receptor is 140 times that of the sigma-1 receptor (IC 50 = 17nM). | ||||
| GC15272 | Troglitazone | 97322-87-7 | >96.00% | |
Troglitazone is an orally active agonist of the peroxisome proliferator-activated receptor γ (PPARγ), with EC 50 values of 550nM and 780nM for human and murine receptors, respectively. | ||||
| GC15399 | Dp44mT | 152095-12-0 | >98.00% | |
iron chelator and anticancer agent | ||||
